Aili Yirizhati, Maimaitiming Nuersimanguli, Mahemuti Yusufu, Qin Hu, Wang Yongxin, Wang Zengliang
Department of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
Department of Oncology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
Front Oncol. 2021 Sep 1;11:686369. doi: 10.3389/fonc.2021.686369. eCollection 2021.
Gliomas are complex and heterogeneous central nervous system tumors with poor prognosis. Despite the increasing development of aggressive combination therapies, the prognosis of glioma is generally unsatisfactory. Exosomal microRNA (miRNA) has been successfully used in other diseases as a reliable biomarker and even therapeutic target. Recent studies show that exosomal miRNA plays an important role in glioma occurrence, development, invasion, metastasis, and treatment resistance. However, the association of exosomal miRNA between glioma has not been systemically characterized. This will provide a theoretical basis for us to further explore the relationship between exosomal miRNAs and glioma and also has a positive clinical significance in the innovative diagnosis and treatment of glioma.
胶质瘤是复杂且异质性的中枢神经系统肿瘤,预后较差。尽管积极的联合治疗不断发展,但胶质瘤的预后总体仍不尽人意。外泌体微小RNA(miRNA)已成功用于其他疾病,作为可靠的生物标志物甚至治疗靶点。最近的研究表明,外泌体miRNA在胶质瘤的发生、发展、侵袭、转移和治疗耐药中起重要作用。然而,胶质瘤之间外泌体miRNA的关联尚未得到系统表征。这将为我们进一步探索外泌体miRNAs与胶质瘤之间的关系提供理论基础,并且在胶质瘤的创新诊断和治疗中具有积极的临床意义。